ASO Author Reflections: Prognostic Value of NCCN Criteria for Resection Following Neoadjuvant Therapy in Localized Pancreatic Cancer

被引：0
|
作者：
Jang, Jong Keon [1 ,2 ]
Byun, Jae Ho [1 ,2 ]
Choi, Se Jin [1 ,2 ]
Kim, Jin Hee [1 ,2 ]
Lee, Seung Soo [1 ,2 ]
Kim, Hyoung Jung [1 ,2 ]
Yoo, Changhoon [3 ]
Kim, Kyu-Pyo [3 ]
Hong, Seung-Mo [4 ]
Seo, Dong-Wan [5 ]
Hwang, Dae Wook [6 ]
Kim, Song Cheol [6 ]
机构：
[1] Univ Ulsan, Dept Radiol, Asan Med Ctr, Coll Med, Seoul, South Korea
[2] Univ Ulsan, Res Inst Radiol, Asan Med Ctr, Coll Med, Seoul, South Korea
[3] Univ Ulsan, Dept Oncol, Asan Med Ctr, Coll Med, Seoul, South Korea
[4] Univ Ulsan, Dept Pathol, Asan Med Ctr, Coll Med, Seoul, South Korea
[5] Univ Ulsan, Dept Gastroenterol, Asan Med Ctr, Coll Med, Seoul, South Korea
[6] Univ Ulsan, Dept Surg, Asan Med Ctr, Coll Med, Seoul, South Korea
来源：
ANNALS OF SURGICAL ONCOLOGY | 2025年 / 32卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1337 / 1338
页数：2
相关论文
共 50 条
  • [1] ASO Author Reflections: Prognostic Value of NCCN Criteria for Resection Following Neoadjuvant Therapy in Localized Pancreatic Cancer
    Jong Keon Jang
    Jae Ho Byun
    Se Jin Choi
    Jin Hee Kim
    Seung Soo Lee
    Hyoung Jung Kim
    Changhoon Yoo
    Kyu-Pyo Kim
    Seung-Mo Hong
    Dong-Wan Seo
    Dae Wook Hwang
    Song Cheol Kim
    Annals of Surgical Oncology, 2025, 32 (2) : 1337 - 1338
  • [2] ASO Author Reflections: Neoadjuvant Therapy Versus Upfront Resection for Pancreatic Cancer
    Andrianello, Stefano
    Marchegiani, Giovanni
    Salvia, Roberto
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : 810 - 811
  • [3] ASO Author Reflections: Neoadjuvant Therapy Versus Upfront Resection for Pancreatic Cancer
    Stefano Andrianello
    Giovanni Marchegiani
    Roberto Salvia
    Annals of Surgical Oncology, 2018, 25 : 810 - 811
  • [4] Survival Outcomes According to NCCN Criteria for Resection Following Neoadjuvant Therapy for Patients with Localized Pancreatic Cancer
    Jang, Jong Keon
    Byun, Jae Ho
    Choi, Se Jin
    Kim, Jin Hee
    Lee, Seung Soo
    Kim, Hyoung Jung
    Yoo, Changhoon
    Kim, Kyu-pyo
    Hong, Seung-Mo
    Seo, Dong-Wan
    Hwang, Dae Wook
    Kim, Song Cheol
    ANNALS OF SURGICAL ONCOLOGY, 2025, 32 (02) : 1321 - 1330
  • [5] ASO Author Reflections: Indication Criteria for Neoadjuvant Therapy for Resectable Pancreatic Ductal Adenocarcinoma
    Shimane, Gaku
    Kitago, Minoru
    Kitagawa, Yuko
    ANNALS OF SURGICAL ONCOLOGY, 2025, 32 (04) : 2866 - 2867
  • [6] ASO Author Reflections: Multimodality Therapy for Patients with Pancreatic Cancer: Neoadjuvant Therapy for All?
    da Costa, Wilson Luiz, Jr.
    Massarweh, Nader N.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (06) : 3196 - 3197
  • [7] ASO Author Reflections: Total Neoadjuvant Therapy with Chemotherapy Alone for Pancreatic Cancer?
    Miller, Phoebe N.
    Nakakura, Eric K.
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (09) : 6203 - 6204
  • [8] ASO Author Reflections: Multimodality Therapy for Patients with Pancreatic Cancer: Neoadjuvant Therapy for All?
    Wilson Luiz da Costa
    Nader N. Massarweh
    Annals of Surgical Oncology, 2021, 28 : 3196 - 3197
  • [9] ASO Author Reflections: Impact of Neoadjuvant Therapy on Survival After Margin-Positive Resection for Pancreatic Cancer
    Asmita Chopra
    Joal D. Beane
    Annals of Surgical Oncology, 2021, 28 : 7770 - 7771
  • [10] ASO Author Reflections: Impact of Neoadjuvant Therapy on Survival After Margin-Positive Resection for Pancreatic Cancer
    Chopra, Asmita
    Beane, Joal D.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (12) : 7770 - 7771
12345